INSIDER · CIK 1445826
Epstein David R
Director at AgomAb Therapeutics NV (AGMB) · Director at Tempus AI, Inc. (TEM)
↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$220KBought on the market
$32KSold on the market
2Companies
Oct 22, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 202608:14 | Oct 21, 2026 | AGMBAgomAb Therapeutics NV | Director | P · Buy | $8.88 | +10,000 | 25,000 | +67% | +$89K | -43.7% | -10.5% |
| Oct 9, 202608:01 | Oct 8, 2026 | AGMBAgomAb Therapeutics NV | Director | P · Buy | $8.90 | +5,000 | 15,000 | +50% | +$45K | -43.6% | -10.7% |
| Oct 7, 202608:57 | Oct 6, 2026from Oct 5, 2026 | AGMBAgomAb Therapeutics NV | Director | P · Buy | $8.64 | +10,000 | 10,000 | New | +$86K | -45.3% | -7.9% |
| Sep 3, 202616:05 | Sep 1, 2026 | TEMTempus AI, Inc. | Director | S · Sell10b5-1 | $65.55 | −250 | 30,844 | -1% | −$16K | ||
| Aug 5, 202616:30 | Aug 3, 2026 | TEMTempus AI, Inc. | Director | S · Sell10b5-1 | $43.40 | −370 | 31,094 | -1% | −$16K |